07:56 AM EDT, 06/24/2024 (MT Newswires) -- G1 Therapeutics ( GTHX ) shares slumped nearly 55% Monday premarket after the company said its treatment candidate for metastatic triple negative breast cancer failed to achieve statistical significance in a late-stage trial and that it will wind down the program.

BitFuFu ( FUFU ) shares retreated 21%, paring Friday's rally.

ResMed ( RMD ) shares fell 11% following a 3.5% loss in the previous session.

Iris Energy Limited ( IREN ) shares dropped 6%, adding to Friday's 4.5% loss.

MicroStrategy ( MSTR ) shares were down 5% following a 1.3% increase in the previous session.

Price: 1.1200, Change: -1.36, Percent Change: -54.84